Unity Biotechnology, Inc.·4

Sep 15, 4:10 PM ET

Dananberg Jamie 4

4 · Unity Biotechnology, Inc. · Filed Sep 15, 2022

Insider Transaction Report

Form 4
Period: 2022-09-14
Dananberg Jamie
Chief Medical Officer
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2022-09-14$0.48/sh10,923$5,243661,213 total
Footnotes (2)
  • [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION